Is Reneo Pharmaceuticals Inc (RPHM) Stock at the Top of the Biotechnology Industry?

A rating of 95 puts Reneo Pharmaceuticals Inc (RPHM) near the top of the Biotechnology industry according to InvestorsObserver. Reneo Pharmaceuticals Inc's score of 95 means it scores higher than 95% of stocks in the industry. Reneo Pharmaceuticals Inc also received an overall rating of 75, putting it above 75% of all stocks. Biotechnology is ranked 81 out of the 148 industries.

RPHM has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on RPHM!

See Full RPHM Report

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. InvestorsObserver makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Reneo Pharmaceuticals Inc Stock Today?

Reneo Pharmaceuticals Inc (RPHM) stock is higher by 2.56% while the S&P 500 is lower by -0.16% as of 10:40 AM on Friday, Oct 6. RPHM has gained $0.19 from the previous closing price of $7.41 on volume of 16,046 shares. Over the past year the S&P 500 is up 13.54% while RPHM has gained 143.59%. RPHM lost -$2.33 per share the over the last 12 months. Click Here to get the full Stock Report for Reneo Pharmaceuticals Inc stock.